SAM staffers give crucial testimony on potency caps in Connecticut

SAM staff members, including our CEO Kevin Sabet, provided crucial testimony at a hearing before the Connecticut legislature on a bill that would endanger the Nutmeg State’s public health by stripping essential potency caps from THC products sold in its legal market.

The key quote, from Kevin’s written testimony:

Removing or weakening these safeguards would be a significant win for the marijuana industry, as it would no longer be restricted from selling ultra-high potency products to consumers. Like any other addiction-for-profit business, the marijuana industry profits from repeat customers. They know that consumers of these high-potency products are much more likely to develop an addiction, which leads to the excessive marketing of and normalization of these products.

You can read the whole thing here.

WANT THE TRUTH ABOUT DRUGS?

Subscribe to The Drug Report to get the latest on science, policy, and much, much more.

It’s all the more important to remember that this misguided bill comes as the wider marijuana industry is suffering. Public support for legal miarjuana has cratered to historic lows; legalization efforts have stalled out, most recently in Hawaii; measures to roll back legal marijuana are advancing to a vote in Massachusetts and elswhere.

Now is no time for people genuinely concerned about public health to back down.

Scroll to Top